Drug intelligence / Profile preview

n,n'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

A **small molecule experimental antiviral compound** containing two 1,3-diazocyclopenta-2,4-dien-4-yl (potentially imidazole-related) groups linked via ethyl diamide bridges to malonic acid. It is primarily referenced as "XC9" and is investigated as part of a **combination therapy** in clinical trials for the treatment of **influenza** and **respiratory syncytial virus (RSV) infection**. The compound appears only in combination with another agent (imidazolylethylamide of pentanedioic acid) in clinical trial protocols, not as a monotherapy. Its mechanism of action is not detailed in the publicly available sources. The compound is at an early stage of clinical development and is not an approved pharmaceutical.

Other names: n,n'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid

Targets

F10 (Factor Xa)

Beyond the preview

Go deeper on n,n'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on n,n'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid.

Explore the full profile